Marrone Bio Innovations, Inc. (MBII)

$1.03

-0.13 (-11.21%)
Rating:
Recommendation:
Buy
Symbol MBII
Price $1.03
Beta 0.358
Volume Avg. 0.80M
Market Cap 187.849M
Shares () -
52 Week Range 0.55-1.7
1y Target Est -
DCF Unlevered MBII DCF ->
DCF Levered MBII LDCF ->
ROE -31.63% Strong Sell
ROA -12.22% Sell
Operating Margin -
Debt / Equity 233.22% Strong Buy
P/E -
P/B 8.21 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest MBII news


Dr. Pamela G. Marrone
Basic Materials
Agricultural Inputs
NASDAQ Capital Market

Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide that controls chewing and sucking insects and mites; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. It provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Raleigh, North Carolina.